BDBM315934 US10172859, Example 358::US9732094, Example 358::[2,4-Difluoro-5-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]pyrrolo[1,2-a] pyrazin-1-ylmethanol1H NMR (500 MHz, DMSO-d6) ppm = 9.12 (s,1H), 8.25-8.19 (m, 1H), 7.94 (t, J = 8.2, 1H), 7.78(dd, J = 2.5, 1.3, 1H), 7.58 (dd, J = 9.3, 3.0, 1H),7.55 (dd, J = 9.4, 2.4, 1H), 7.47-7.39 (m, 2H),7.22 (d, J = 2.3, 1H), 6.97-6.93 (m, 1H), 6.91 (dd,J = 4.1, 2.5, 1H), 6.43 (d, J = 5.9, 1H), 6.30 (d,J = 5.9, 1H), 3.82-3.76 (m, 4H), 3.49-3.44 (m,4H).
SMILES: OC(c1cc(c(F)cc1F)-c1ncnc2cc(ccc12)N1CCOCC1)c1nccn2cccc12
InChI Key: InChIKey=WWULIMQUQVVHHC-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM315934 (US10172859, Example 358 | US11065253, Example 358 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been ... | US Patent US9732094 (2017) BindingDB Entry DOI: 10.7270/Q2J67K1S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM315934 (US10172859, Example 358 | US11065253, Example 358 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go re... | US Patent US10172859 (2019) BindingDB Entry DOI: 10.7270/Q23B626S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
DNA-dependent protein kinase catalytic subunit (Homo sapiens (Human)) | BDBM315934 (US10172859, Example 358 | US11065253, Example 358 ...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
DNA-dependent protein kinase catalytic subunit (Homo sapiens (Human)) | BDBM315934 (US10172859, Example 358 | US11065253, Example 358 ...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description The kinase assay was carried out in streptavidin-coated 348-well microtitre flashplates. To this end, 1.5 μg of DNA-PK/protein complex and 100 n... | US Patent US10172859 (2019) BindingDB Entry DOI: 10.7270/Q23B626S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
DNA-dependent protein kinase catalytic subunit (Homo sapiens (Human)) | BDBM315934 (US10172859, Example 358 | US11065253, Example 358 ...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description The kinase assay was carried out in streptavidin-coated 348-well microtitre flashplates. To this end, 1.5 ug of DNA-PK/protein complex and 100 ng of ... | US Patent US9732094 (2017) BindingDB Entry DOI: 10.7270/Q2J67K1S | |||||||||||
More data for this Ligand-Target Pair |